Register a trial

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT03937245




Registration number
NCT03937245
Ethics application status
Date submitted
1/05/2019
Date registered
3/05/2019

Titles & IDs
Public title
Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care
Scientific title
Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care: the Eurobact II Multinational Cohort Study
Secondary ID [1] 0 0
EurobactII
Universal Trial Number (UTN)
Trial acronym
EurobactII
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Bacteremia 0 0
Sepsis 0 0
Hospital Acquired Condition 0 0
Resistance Bacterial 0 0
Condition category
Condition code
Infection 0 0 0 0
Studies of infection and infectious agents
Infection 0 0 0 0
Other infectious diseases
Blood 0 0 0 0
Other blood disorders
Inflammatory and Immune System 0 0 0 0
Other inflammatory or immune system disorders

Intervention/exposure
Study type
Observational [Patient Registry]
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
HA-BSI - Patients with HA-BSI treated in an ICU
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Mortality
Timepoint [1] 0 0
28 days
Secondary outcome [1] 0 0
Progress of organ failures
Timepoint [1] 0 0
7 days
Secondary outcome [2] 0 0
Days free or organ supportive therapy
Timepoint [2] 0 0
28 days
Secondary outcome [3] 0 0
Clinical cure
Timepoint [3] 0 0
7 days, 28 days
Secondary outcome [4] 0 0
Microbiological cure
Timepoint [4] 0 0
7 days, 28 days

Eligibility
Key inclusion criteria
* Age > 18 Years.
* Hospital Acquired Bloodstream Infection (HA-BSI).
* Treated in the ICU.

* ICU acquired OR
* Hospital acquired prior to ICU admission
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Patients that had a positive blood culture in the hospital and transferred to ICU for a different reason than specific treatment of the causes or consequences of HA-BSI.
* Previous inclusion in the study.

* HA-BSI is defined as a positive blood culture (BC) sampled after 48 hours following hospital admission.

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
30/08/2019
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
3/06/2021
Sample size
Target
Accrual to date
Final
3058
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 0 0
Redcliffe Hospital - Brisbane
Recruitment postcode(s) [1] 0 0
4020 - Brisbane
Recruitment outside Australia
Country [1] 0 0
France
State/province [1] 0 0
Paris

Funding & Sponsors
Primary sponsor type
Other
Name
Outcome Rea
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
European Society of Intensive Care Medicine
Address [1] 0 0
Country [1] 0 0
Other collaborator category [2] 0 0
Other
Name [2] 0 0
European Society of Clinical Microbiology and Infectious Diseases
Address [2] 0 0
Country [2] 0 0
Other collaborator category [3] 0 0
Government body
Name [3] 0 0
Institut National de la Santé Et de la Recherche Médicale, France
Address [3] 0 0
Country [3] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Alexis Tabah, MD
Address 0 0
ICU, Redcliffe Hospital, Faculty of Medicine, UQ, Brisbane, QLD, Australia.
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Undecided
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?




Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT03937245